The effect of ContrAst media Temperature on patient comfort in Computed tomograpHYof the abdomen. (CATCHY trial)

The effect of ContrAst media Temperature on patient comfort in Computed tomograpHYof the abdomen. (CATCHY trial) - Contrast media temperature and patient comfort in abdominal CT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON48194

Enrollment

216

Registered

2019-11-27

Start date

2020-02-03

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alle aandoeningen waarvoor een patient een CT in portaal veneuze fase krijgt. Abdominal diseases

Interventions

NVT

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients referred for a CT of the abdomen Patients >= 18 and competent to sign an informed consent.

Exclusion criteria

Exclusion criteria: o Hemodynamic instability o Pregnancy o Renal insufficiency defined as glomerular filtration rate (GFR)

Design outcomes

Primary

Measure	Time frame
To evaluate the degree of patient discomfort during the injection of CM at room temperature (20C) with a concentration of 300 mg/ml, compared to pre-warmed CM (37C). We hypothesize that there is a disadvantage in patient comfort when CM is not preheated. We will evaluate general comfort levels, as well as vasovagal reactions, CM extravasation, shivering, cold feeling and goosebumps after CM injection. It is expected that the differences in CM temperatures will not influence subjective and objective IQ. Th	—

Measure

Time frame

To evaluate the degree of patient discomfort during the injection of CM at room temperature (20*C) with a concentration of 300 mg/ml, compared to pre-warmed CM (37*C). We hypothesize that there is a disadvantage in patient comfort when CM is not preheated. We will evaluate general comfort levels, as well as vasovagal reactions, CM extravasation, shivering, cold feeling and goosebumps after CM injection. It is expected that the differences in CM temperatures will not influence subjective and objective IQ. Th

—

Secondary

Measure	Time frame
Injection parameters (e.g. time to peak, bolus homogeneity and time pressure curve) will be evaluated.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)